WITH troubles at Corning/Quest and LabCorp attracting publicity during the previous 18 months, few people observed a discreet but important change at SmithKline Beecham Clinical Laboratories (SBCL). John B. Okkerse, Jr., Ph.D. has quietly assumed full executive responsibility at the $1 billion company. Although Okkerse was promoted to President in 1995, Vickery Stoughton was the Chief […]
To access this post, you must purchase The Dark Report.